DCAKD: A Potential Drug Target and Biomarker for Various Diseases

Target Name: DCAKD

NCBI ID: G79877

DCAKD: A Potential Drug Target and Biomarker for Various Diseases

DCAKD (Dephospho-CoA kinase domain-containing protein) is a protein that is expressed in various cell types of the human body. It plays a crucial role in the metabolism of fatty acids, which are essential for the body's growth and development. The DCAKD protein has been shown to be a potential drug target or biomarker in various diseases, including cancer, cardiovascular disease, and neurological disorders.

DCAKD: Structure and Function

DCAKD is a protein that contains a unique domain called the DCAKD kinase domain. This domain is responsible for the protein's catalytic activity and is similar to other kinases that are known to be involved in the phosphorylation of intracellular targets. The DCAKD protein is composed of 154 amino acids and has a calculated molecular mass of 17.5 kDa.

The DCAKD protein functions as a catalytic enzyme that is involved in the metabolism of fatty acids. It is highly specific for its target, which is the CoA-SH (Co-A sulfonyl), which is a key intermediate step in the citric acid cycle. The DCAKD protein catalyzes the conversion of CoA-SH to CoA-S-CoA, which is a critical step in the citric acid cycle and is involved in the production of energy.

DCAKD has been shown to play a crucial role in the regulation of various cellular processes, including cell growth, differentiation, and metabolism. It has been shown to promote the growth and survival of cancer cells, and to contribute to the development of neurodegenerative diseases.

DCAKD as a Drug Target

DCAKD has been identified as a potential drug target due to its involvement in the regulation of cellular processes that are associated with various diseases. One of the main targets of DCAKD is the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to the development of oxidative stress-induced diseases.

DCAKD has been shown to be involved in the production of ROS by promoting the production of superoxide anion (O2鈥?-), which is a byproduct of the oxidation of fat. This process is thought to contribute to the development of various diseases, including cancer , cardiovascular disease, and neurodegenerative diseases.

In addition to its role in the production of ROS, DCAKD has also been shown to be involved in the regulation of cellular responses to stress and in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of cell survival and in the modulation of cellular signaling pathways that are involved in cell growth, differentiation, and metabolism.

DCAKD as a Biomarker

DCAKD has also been identified as a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. This is because it is expressed in various tissues of the body and can be used as a marker for the presence of specific diseases.

DCAKD has been shown to be expressed in a variety of tissues, including the brain, heart, liver, and muscle. It has also been shown to be involved in the regulation of various cellular processes that are involved in the development and progression of these diseases . For example, DCAKD has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its potential as a biomarker, DCAKD has also been shown to be involved in the development of certain diseases. For example, DCAKD has been shown to contribute to the development of cancer by promoting the production of ROS and by contributing to the regulation of cellular signaling pathways that are involved in cell growth and survival.

Conclusion

In conclusion, DCAKD is a protein that is involved in

Protein Name: Dephospho-CoA Kinase Domain Containing

More Common Targets